In Drosophila, much has been learned about the specification of neuronal cell fates but little is known about the lineage of mesodermal cells with different developmental fates. Initially in development, individual mesodermal precursor cells are singled out to become the founder cells for specific muscles. The selection of muscle founder cells is thought to employ a Notch-mediated process of lateral inhibition, similar to what is observed for the specification of neural precursors. These muscle founder cells then seem to fuse with the surrounding, uncommitted myocytes inducing the formation of muscle fiber syncytia. In contrast, the differentiated progeny of neural precursor cells are usually the result of a fixed pattern of asymmetric cell divisions which are directed, in part, by interactions between Numb, a localized intracellular-receptor protein, Sanpodo (Spdo), a potential tropomodulin homolog, and Notch, a transmembrane receptor protein. Here, we have investigated the role of these neural lineage genes in the cell fate specification of muscle and heart precursors. In particular, we have focused on a progenitor cell that is likely to produce a mixed lineage, generating both a pericardial heart cell and a somatic muscle founder cell. We show that the asymmetric segregation of Numb into one of these daughter cells antagonizes the function of Notch and spdo by preventing the presumptive muscle founder from assuming the same fate as its cardiac sibling. Our results suggest that asymmetric cell divisions, in addition to the previously-documented inductive mechanisms, play a major role in cardiac and somatic muscle patterning and that additionally the cytoskeleton may have a role in the asymmetrical localization of cell fate determinants.
Introduction
During embryological development, cellular differentiation often involves a cycle of asymmetric cell division which results in the production of two distinct daughter cells with different developmental fates. One mechanism for generating asymmetric cell division involves a cytoplasmic or membrane-associated determinant that can be asymmetrically localized in the predivisional cell and that segregates to only one of the daughter cells. In the nervous system of Drosophila, the product of the gene numb is a membrane-associated protein that has been shown to be necessary and sufficient for determining alternative daughter cell fates during asymmetric cell divisions (Uemura et al., 1989; Rhyu et al., 1994; Spana et al., 1995; Brewster and Bodmer, 1995; Guo et al., 1996; Spana and Doe, 1996 ; for recent review see Vervoort et al., 1997) . One gene which interacts with numb is Notch (N), which encodes a transmembrane receptor protein containing multiple EGF-like repeats in its extracellular domains (Wharton et al., 1985) . In the daughter cell that inherits the Numb protein, signaling via the Notch receptor is inhibited, resulting in a cell that assumes a different fate from its sibling (Guo et al., 1996; Spana and Doe, 1996) . spdo is another gene that appears to be involved in the Numb-mediated determination of alternative cell fates (Salzberg et al., 1994) . This gene encodes a tropomodulin-like protein and as N acts antagonistically to numb (Dye et al., 1998; Skeath and Doe, 1998) . Since tropomodulin can associate with actin, it has been suggested that some forms of Notch-mediated signaling in the nervous system may include a cytoskeleton-based mechanism to transduce information from the membrane to the nucleus and that Spdo is necessary in this process.
The heart and other muscles in Drosophila embryos are highly organized and stereotypically arranged tissues and their development is beginning to be understood in considerable detail (for descriptions and reviews see Bate, 1993; Abmayr et al., 1995; Bodmer et al., 1997) . The somatic muscles of the body wall musculature are syncytial fibers arranged in a complex segmental pattern. Formation of these muscles seems to be initiated by founder cells that emerge at distinct locations in the mesoderm and fuse with surrounding myoblasts (Bate, 1990; Dohrmann et al., 1990; Michelson et al., 1990; Bour et al., 1995; Rushton et al., 1995) . In contrast, the heart consists of mononucleate cells that derive from bilaterally symmetrical precursors at the dorsal-most edge of the mesoderm. These cells form a linear heart-tube extending along most of the embryo (Bodmer et al., 1990; Rugendorff et al., 1994) . During and after gastrulation, inductive signals from the ectoderm, in combination with mesoderm-endogenous transcription factors, are responsible for the first subdivisions of the mesoderm which result in a distinction between a cardiac versus visceral mesodermal fate (reviewed in Bodmer et al., 1997) . The way in which the founder cells of individual muscles are specified, seems to be similar to the mechanism for neural precursor determination in the central and peripheral nervous system (the neuroblasts and sensory-organ precursors, respectively; for review see Vervoort et al., 1997) : 'neural competence' genes (e.g. the proneural genes of the achaetescute complex) first define the mesodermal region of muscle founder competence (Carmena et al., 1995) . From these areas, individual muscle founder progenitors (as neuroblasts and sensory organ precursors) are then singled out by a cellcell interaction process of lateral inhibition mediated by the 'neurogenic' genes (such as N) (Corbin et al., 1991; Bate et al., 1993) .
In contrast to the nervous system, the role of fixed lineages in cell fate determination during mesoderm development is less well studied. Previous transplantation experiments involving individual early gastrula cells did not suggest any obvious lineage restrictions within the mesoderm (Beer et al., 1987) , although these studies could not rule out that certain mesodermal lineages are fixed at a later stage. More recent evidence indeed implies that certain myogenic progenitor cells may have fixed lineages giving rise to the founder cells of specific muscles and other mesodermal cell types (Carmena et al., 1995 (Carmena et al., , 1998 this work) .
Here, we show that a numb/N-dependent mechanism also specifies cell fates within the mesoderm, by controlling somatic muscle (see also Uemura et al., 1989; Carmena et al., 1998) and heart cell identities (this study). In addition, we show that the newly identified lineage gene, spdo (Dye et al., 1998) , is also involved in mesodermal cell fate decisions. The mixed cardiac-muscle founder lineage of the Evenskipped-expressing (Eve) myogenic progenitors (as determined by the flp/ FRT lineage-tracing method; Struhl and Basler, 1993; Brewster and Bodmer, 1995) has been studied in detail. Our data demonstrate that an asymmetric distribution of Numb protein between the daughter cells of the Eve progenitor results in the production of distinct daughter cells: one having a muscle founder fate and the other a cardiac cell fate. In the cell that inherits the Numb protein (which has a muscle founder cell fate) the function of N and spdo is apparently inhibited, similar to what is observed for neuronal precursors. In the daughter cell that lacks the Numb protein (which has a pericardial cell fate), signal transduction by n is not inhibited and likely to be mediated by Spdo, possibly in association with actin filaments. Given the similarities between the mechanisms of neuronal and muscle cell specification it becomes likely that the alternative cell fate decisions mediated by numb, N and spdo are of general developmental significance.
Results

numb and spdo have opposite effects in the specification of muscle founder cells
To investigate the possible role for numb in specifying muscle identities, we examined Kruppel (Kr, Gaul et al., 1992) and S59 expression (Dohrmann et al., 1990 ) in a distinct subset of mesodermal precursor cells. These mesodermal precursors are likely the putative founder cells of identified muscles of the body wall (Bate, 1990; Carmena et al., 1995 Carmena et al., , 1998 (Fig. 1A,C) . In all numb mutant embryos examined, the number of Kr and S59 expressing muscle precursor cells is dramatically reduced or absent in stage 12/13 embryos ( Fig. 1A-D ; similar observation were also made by Ruiz Gómez and . The expression of putative muscle founder markers other than Kr and S59 (summarized in Abmayr et al., 1995) is also affected in numb mutants (data not shown). Thus, numb function is required either for the formation of the Kr and S59 expressing cells, and perhaps the corresponding muscles, or for the expression of Kr and S59 in these cells without interfering with muscle formation per se.
To determine if the normal pattern of muscle formation is affected in numb mutants, we examined the pattern of differentiating muscles at a later embryonic age with antibodies against muscle myosin that outline muscle syncytia (Kiehart and Feghali, 1986) and antibodies against Dmef2, a transcription factor present in all contractile muscle nuclei Lilly et al., 1995) . In numb mutants, myosin-containing muscle syncytia (data not shown) and Dmef-containing muscle nuclei are much fewer in number, in particular in the dorsal region (Fig.  1E,F) . To quantify these findings, we determined the fre-quency by which the four dorsal-most muscles (DA1, DA2, DO1 and DO2; nomenclature according to Bate, 1993) were present in numb mutant embryos, as determined by myosin expression. Muscle DA1, which corresponds to the dorsalmost Kr expressing founder cell , is present as a myosin-expressing muscle fiber in only 8% (n = 140 hemi-segments). DA2 is present in 5.5%, DO1 in 21% and DO2 in 15% of the hemi-segments examined. This clearly indicates that, at least in the dorsal region examined, not only is muscle founder marker expression affected in numb mutants but formation of the corresponding muscles is abolished altogether in the majority of the cases. Prior to the stage when the Kr and S59 markers begin to be expressed, mesoderm development and subdivision into somatic, visceral and cardiac progenitors appears to be normal (data not shown). Taken together, these data suggest that numb is necessary for the correct specification of individual muscle identities of the body wall musculature, but not for the prerequisite distinction between the mesodermal layers.
Since in neuronal lineages the presence of Numb protein is apparently required to inhibit N and spdo function (Guo et al., 1996; Spana and Doe, 1996; Dye et al., 1998; Skeath et al., 1998) , we expect that reducing N and spdo function results in a mesodermal phenotype that is opposite to that of numb loss-of-function mutants. In addition, overexpression of numb that causes mis-localization of Numb protein (to both daughter cells) should also produce a phenotype that is opposite to that of loss-of-numb-function. Indeed, in spdo mutant embryos the number of S59 (data not shown) and Kr expressing muscle founders is increased (Fig. 1G ). This phenotype is particularly evident in the dorsal region (arrowhead in Fig. 1G , compare with Fig. 1A ). This suggests that spdo function is needed for muscle cell fate specification, similar to its role in neural lineages. In addition, mesodermally overexpressed numb using the Gal4 system (Brand and Perrimon, 1993) also generates an overabundance of Kr expressing muscle precursors (Fig. 1H) . Because of the high degree of structural disorganization in the mutants, we were unable to determine the identities of the different muscles or muscle founders in the dorsal region of spdo mutants and with numb overexpression. Taken together, these results suggest that numb specifies alternative muscle founder cell fates in a lineage-dependent fashion similar to the situation in the nervous system.
numb and spdo distinguish between alternative cell fates of the mesodermal Eve-progenitor lineage
To analyze in detail the numb-dependent mechanism of assigning muscle cell fates we concentrated on a single dorsal muscle, DA1, and its sibling (see below), a non-muscle pericardial cell (termed EPC), which is associated with the heart. Both cell types express Eve; however, they can be distinguished morphologically ( Fig. 2A,B) . The precursor cells for both the EPCs and the putative founders of DA1 muscles emerge from a small cluster of mesodermal Eveexpressing cells in each hemi-segment at mid-stage 11 (Fig.  2C ). At first, these mesodermal Eve cells are indistinguishable from each other, and they co-express Dmef2, which is expressed in the entire early mesoderm and later in all (contractile) muscle types Lilly et al., 1995) . Subsequently, Dmef2 expression ceases in the future EPCs as they begin to differentiate as non-muscle, pericardial cells (arrowheads in Fig. 2C ). The putative DA1 founder seems to maintain Dmef2 expression (arrow in Fig. 2C ) and begins fusing with surrounding myocytes. In Dmef2 mutants, no fusion occurs but the putative muscle founders maintain expression of their muscle precursor markers, such as Eve .
In numb mutants, most DA1 muscles are physically absent (see above) and the remaining ones lack Eve (and Kr) expression; in addition, the number of EPCs is doubled (Fig. 2D , see also Fig. 1F ): In wildtype (after stage 14), there are 16 ± 0.4 (SEM, n = 50) EPCs per half embryo caudal to the lymph gland (see Fig. 2A ). In numb mutants of the same stage, there are 30 ± 2.4 (n = 50) EPCs. The initial number of Eve expressing precursors at stage 11, however, is unchanged (data not shown). These data suggest that in numb mutants the putative DA1 founders are transformed into EPCs, because the Eve progenitor cells that normally give rise DA1 founders and EPCs now only produce EPCs. If the normal function of numb is to distinguish between a DA1 founder cell fate and an EPC fate as a result of asymmetric cell division, we predict that overexpression of numb or the loss-of-spdo-function will result in a failure to generate EPCs but allowing formation of DA1 muscles. Indeed, in embryos with mesodermal overexpression of numb as well as in spdo loss-of-function mutants the DA1 muscles do form but hardly any EPCs are detected in all embryos (Fig. 2E,F) . This suggests that the cell fates in mesodermal precursors are controlled by a numb-dependent mechanism.
Although the numb mutant phenotype suggests that DA1 muscle precursors and EPCs may be related by lineage, an alternative scenario it is also possible that the DA1 founders and the EPCs derive from independent precursors. In order to address this issue, we first determined the number of mesodermal Eve cells that are specified in the absence of cell division. In string mutant embryos, in which cell division is arrested at blastoderm (Edgar and O'Farrell, 1989) , usually two mesodermal Eve expressing cells are formed per hemi-segment (Fig. 2G) . This is consistent with a model in which initially two mesodermal Eve cells are specified per hemi-segment that divide asymmetrically, and under the control of numb, each giving rise to two daughter cells, an EPC and a DA1 founder (Fig. 2H) . The fact that in some segments of string mutant embryos fewer than two mesodermal cell express Eve may simply be due to the limited availability of cells in these cell division-arrested embryos.
To test the proposed lineage model directly, we used the flp/FRT lineage-tracing method to generate random clones of reporter gene expression (Struhl and Basler, 1993; Brewster and Bodmer, 1995) . We induced clones at stage 10, which is about 1 h before the emergence of the first mesodermal Eve-expressing cells. By examining several thousand embryos with clones, we observed 52 cases in which the reporter gene-expressing clone contained at least one mesodermal Eve cell that was labeled. Of these, the majority (70%) showed co-labeling of one EPC and the DA1 muscle (Fig. 2I) . Not all the muscle nuclei were labeled and usually more weakly than the EPC, which is not unexpected since the putative muscle founder is thought to fuse with surrounding myoblasts, thus diluting the reporter gene product in the syncytium. In 8% of the cases, two EPCs were labeled but no lineage marker could be detected in the DA1 muscle. In 16%, either two EPCs and the DA1 muscle or contractile cardiac cells where co-labeled. In 6%, only the DA1 muscle was labeled. The moderate variability in the types of observed clones may be because (this) muscle precursor lineages are not fixed as strictly as neuronal lineages. It is also possible that the two (neighboring) EPC precursors in one segment (Fig. 1G) , although not specified in a lineage-dependent fashion, happen to be siblings at some frequency. Moreover, those cases with only EPC labeling can be explained by a dilution of the clonal marker in the forming muscle syncytium that was sufficient to escape detection. Nevertheless, these data support the hypothesis that, usually, EPCs and DA1 muscle founders derive from a mixed cardiac/somatic muscle lineage. This lineage model differs from that proposed in a recent report (Carmena et al., 1998) , in which the lineages were based on observing marker gene expression patterns (see Section 3).
If numb indeed controls alternative cell fates during asymmetric Eve precursor divisions, as our genetic and lineage data suggest, it would be expected that Numb protein localizes asymmetrically within these Eve precursors. Indeed, we find that Numb protein is present in a crescent-shaped region in Eve progenitors and subsequently appears to segregate to one of the daughter cell, which, in analogy to the nervous system (Spana et al., 1995) , is likely to become the putative DA1 founder (Fig. 2J) .
Notch signaling participates in alternative mesodermal cell fate decisions
To further explore the mechanism of numb-dependent cell fate specification within the mesoderm further, we wanted to determine whether or not N is also involved in 
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/spdo K433 mutant embryo showing that the EPCs are almost completely absent (asterisks, arrowhead points to a remaining EPC) but the presence of the DA1 muscles seems unaffected (arrows). (F) Similar to spdo mutants, when Numb is ubiquitously overexpressed in the mesoderm using the GAL4-system (twi-24B-Gal4, UAS-numb), the DA1 muscles are formed but the EPCs are drastically reduced. (G) Portion of stage 11 string mutant embryo showing two Eve-expressing cells per hemi-segment (arrowheads). (H) Lineage model of Even-skipped expressing mesodermal cells: two cells per hemi-segment are specified as Eve positive mesodermal progenitor cells, which are proposed to each divide asymmetrically to give rise to two daughter cells with different cell fates, an EPC (red) and a DA1 founder (green). Although in this model two potential DA1 founder cells may be produced, only one nucleus with Kr protein is observed. This may be because they fuse to form a binucleate founder (see Bate, 1990) , or alternatively, one of them dies or assumes an unidentified fate. In addition, we could not unambiguously determine if more than one DA1 muscle differentiates per hemi-segment in spdo mutants or in embryos with numb overexpression, because of the moderate disorganization of the differentiated muscle pattern in these mutants. the EPC versus DA1 distinction. In loss-of-function mutants that removes both the zygotic and maternal components N (by generating germline clones), the mesodermal Eve clusters are initially enlarged (Fig. 3A,B) , but EPCs fail to form and Eve expression is only observed in DA1 muscles (Fig.  3C, arrowheads) . On the other hand, in strong N gain-offunction mutants (generated by pan-mesodermal overexpression of a constitutively-active form of N, N intra , Lieber et al., 1993) , no mesodermal Eve expressing cells are formed at all (Fig. 3D) . This is apparently due to a lack of mesodermal subdivision (since visceral mesoderm is not formed either, data not shown), which normally occurs prior to the assignment of individual muscle cell fates. Nevertheless, these data are consistent with the interpretation that, initially, the number of mesodermal Eve progenitor cells is controlled by a N-dependent mechanism of lateral inhibition, as for other muscle progenitors (Corbin et al., 1991; Carmena et al., 1995) . And later, N functions once again to promote EPC formation in those cells that do not inherit Numb protein.
In order to directly examine the role of N in EPC determination, we induced expression of N intra via a heat-shock promoter at late stage 11, which is shortly after the time of initial Eve cluster formation (and much later then the panmesodermal N intra expression described above). Similar to what we observed for numb mutants, DA1 muscles usually fail to form and the number of EPCs is much increased (26 ± 4.5, n = 50; Fig. 3E ; compare with Fig. 2D ). Not only are the DA1 muscles affected by N, but the number of mesodermal cells expressing Kr (Fig. 3F ) and S59 (data not shown) is much reduced as well. This phenotype, which was observed upon conditional induction of N gain-of-function activity, is similar to the numb mutant phenotype (see Figs. 1B and 2D) . Thus, the numb/N/spdo-dependent pathway apparently is not only involved in neural cell fate specification, but also during asymmetric cell divisions within the mesoderm.
sanpodo and Notch are epistatic to numb in the mesodermal Eve progenitor lineage
In order to determine whether numb, N and spdo interact with each other during the proposed alternative cell fate decisions in the mesoderm, we examined both the mesodermal and neuronal phenotype with respect to Eve protein expression in embryos homozygous mutant for both numb and spdo. As a control, we first looked at the nervous system. Eve is present in the RP2 neurons of the wildtype CNS ( Fig. 2A) , but appear to be absent in numb mutants and doubled in spdo mutants (data not shown, Skeath and Doe, 1998) . In numb, spdo double mutant embryos, Eve expressing RP2 neurons are doubled (Fig. 4B) as in spdo mutants alone. In the same double mutants, the Eve expressing DA1 muscles are present in most segments, but the majority of the EPCs fail to form (Fig. 4C , same embryos as in Fig. 4B, compare with Fig. 2E) . Thus, the data indicate that spdo is epistatic to numb, suggesting that it acts downstream of numb.
We then examined the phenotype of a double mutant combination of N and numb. Since in strong N loss-of-function mutants the muscles, including DA1, do not form reliably (see Fig. 3C ), we chose to generate a gain-of-function situation by increasing N as well as numb activity in the same embryo. Induction of N intra in late stage 11 embryos with pan-mesodermal numb overexpression show a similar phenotype than embryos with N intra induction alone: the number of EPCs is increased and hardly any DA1 muscles form (Fig. 4D, compare with Fig. 3E ). Thus, not only spdo but also N seems to be epistatic to numb. Although our results are consistent with this interpretation, the epistatic order of numb and Notch is less certain than that between numb and spdo, since it is based on gain-of-function situations.
Discussion
We have shown that three components of a pathway that direct alternative cell fate decisions during asymmetric cell division in the nervous system have a similar activity in the mesoderm: the phenotype of gain-and lossof-function mutants in the genes numb, Notch and spdo have shown that their normal functions are crucial for distinguishing between muscle identities or between muscle and non-muscle fates (see also Ruiz Gómez and Carmena et al., 1998 ; a numb muscle phenotype was first reported by Uemura et al., 1989) . We have established the epistatic relationship between these three genes for the mesodermal Eve progenitor lineage, which produces the founders for the DA1 muscles and the heart associated EPCs. Based on these experiment, we propose that asymmetrically segregated Numb protein in Eve progenitor lineages antagonizes N and spdo activity in the presumptive DA1 founders, thus allowing muscle development; whereas in their sibling EPCs N and spdo contribute to the establishment of a non-muscle pericardial cell fate (Fig. 4E) . Thus, the numb/N/spdo pathway seems to specify alternative cell fates not only of neural, but also of mesodermal lineages.
Since the same genetic components act within neural and mesodermal progenitors, they themselves cannot be the determinants of particular cellular identities, rather they act as a switch mechanism that determines which of two possible routes cells may take when they differentiate. Thus, in conjunction with the numb/N/spdo 'switch', an (Fig. 2E) . (D) Representative phenotype of a stage 15 embryo with mesodermal numb overexpression (as in Fig. 2F ) and induction of hsN intra at mid-to-late stage 11 (as in Fig. 3E ) in the same embryo (genotype: twi-24B-Gal4, UASnumb, hsN intra ). Note the increased number of EPCs (arrowheads) and the absence of DA1 muscles in most segments (asterisks), thus similar to the phenotype of conditional induction of hsN intra by itself (Fig. 3E ). An occasional DA1 muscle is indicated (arrow). (E) Genetic interaction model of numb, Notch and spdo in mesodermal (Eve) cell fate decisions. Asymmetrically localized Numb protein (green) in a mesodermal Eve precursors seems to segregate, upon division, to one of the daughter cells (see also Fig. 2J ). numb function apparently represses Notch and spdo activity in the daughter cell that inherited Numb protein, and thus allows the formation of the DA1 muscle. Conversely, in the sibling cell without Numb, Notch signaling either suppresses muscle founder formation or promotes EPC differentiation.
asymmetrically dividing cell must possess its own particular identity or competence to activate the tissue-appropriate set of target genes. In the nervous system, the gene tramtrack has been shown to be regulated in a numb/N-dependent fashion (Guo et al., 1996) . Since we have been unable to identify a role for tramtrack in EPC or muscle founder formation (data not shown), it is possible that tramtrack is a nervous system-specific target gene, and that in the mesoderm the numb/N/spdo pathway controls yet another set of targets. In vivo studies during post-embryonic development, as well as in vitro studies have implicated Suppressor of Hairless (Su(H)) as a mediator of N signaling (Fortini and Artavanis-Tsakonas, 1994; Lecourtois and Schweisguth, 1995; Schweisguth et al., 1996; Wang et al., 1997) . However, because of the strong maternal contribution of Su(H), functional studies in the embryo have thus far been inconclusive (F. Schweisguth, pers. commun.) .
The participation of spdo-encoded tropomodulin in cell fate specification during numb-dependent asymmetric cell divisions in the nervous system (Dye et al., 1998; Skeath and Doe, 1998) as well as in the mesoderm (this study) suggests that the cytoskeleton is likely to play a crucial role in this process. One possibility is that tropomodulin mediates signal transduction, perhaps by an actin-associated transport mechanism from the membrane to the nucleus. Alternatively, spdo could be involved in the asymmetric localization of cell fate determinants associated with the plasma membrane or within the cytoplasm. It is, however, unlikely that spdo function is needed for the asymmetric distribution of Numb protein itself, since it appears to be epistatic to numb and thus likely to act downstream of numb.
In spdo mutants and in embryos where numb is overexpressed we observed several-fold the normal number of dorsal Kr-positive muscle founder cells (Fig. 1G,H) . If normally these Kr founders arise from an asymmetric cell division, one would expect only twice as many. It is possible that the progeny of other progenitor cells show ectopic Kr expression, which could account for the extra Kr nuclei. Another possibility is that the nuclei of the myocytes which are fusing with the dorsal Kr founders express Kr prematurely in these mutants as compared to wildtype, thus resulting in additional Kr-positive nuclei at the time when normally only the founder nuclei contain Kr. In the case of Eve, the syncytial myocyte nuclei contain Eve protein immediately after fusion with the DA1 progenitor (data not shown).
Our genetic data in conjunction with an independent lineage analysis suggest strongly that the divisions of Eveexpressing mesodermal progenitors are asymmetric, producing both DA1 muscle founder cells as well as the heartassociated EPCs (Fig. 4E) . The lineage we propose here for the Eve progenitor cells differs from that reported by Carmena et al. (1998) , which is exclusively based on marker gene expression patterns. They postulate that one of the two Eve progenitors per hemisegment produces the DA1 founder and the other gives rise to both EPCs. Based on our data with the flp/FRT based clonal analysis, this seems unlikely since we hardly ever observe expression of the lineage tracer in both EPCs, as it would be predicted by their model. Since both lineage models include the formation of cells whose fate has not yet been determined, additional markers and lineage studies are necessary to elucidate the exact lineages of these and other mesodermal progenitors cells.
The fact that a similar set of genes appears to be involved in asymmetric divisions in both nervous system and mesoderm differentiation leads us to hypothesize that these genes may constitute a general genetic switching mechanism that is used by a number of different tissue types in Drosophila. This mechanism may not be limited to Drosophila; indeed, numb has been identified also in vertebrates and shown to be localized asymmetrically during ventricular stem cell divisions (Verdi et al., 1996; Zhong et al., 1996) . As in Drosophila, vertebrate numb is found in most tissues including the developing heart and muscles. Thus, it may very well be that numb controls cell fate decisions of mesodermal lineages also in vertebrates.
Experimental procedures
Drosophila stocks numb
1 (numb neo7 ) and numb 2 were originally isolated in the Jan lab (Uemura et al., 1989; Rhyu et al., 1994) . The numb 2 mesodermal phenotype studied in this paper was found to be slightly stronger than that of numb 1 . spdo ZZ27 (Skeath and Doe, 1998) , spdo K433 (Salzberg et al., 1994) , string 76 (Edgar and O'Farrell, 1989) and N 246-40 (obtained from N. Perrimon) are all strong alleles. The UAS-N intra and hsN intra lines are described in Lieber et al., 1993) , the twiGal4 line in Greig and Akam (1993) , and the 24B-Gal4 line in Brand and Perrimon (1993) . Combination of these two Gal4 drivers provide UAS-dependent pan-mesodermal expression from stage 9/10 until at least stage 15 (data not shown). The UAS-numb construct has been provided by J. Ooj and B. Margolis (Yaich et al., 1998) . Double mutant combinations have been generated using lacZ-marked balancer chromosomes. Homozygous mutant embryos were identified by the lack of lacZ product.
Antibody staining
Whole-mount embryo staining with primary antibodies and HRP-coupled secondary antibodies was essentially carried out as described previously (Brewster and Bodmer, 1995) . In some cases the Elite kit (Vector) was used. Anti-Eve (Frasch et al., 1987) , anti-Kr (Gaul et al., 1987) , anti-Dmef2 (Lilly et al., 1995) , anti-DMM (Kiehart and Feghali, 1986) , anti-S59 (Dohrmann et al., 1990 ) and antiNumb (Rhyu et al., 1994) antibodies were used as described. For double labeling with fluorescent secondary antibodies for confocal image analysis we used Cy3-coupled anti-rab-bit IgG (Jackson) to visualize Eve protein and streptavidincoupled anti-rabbit IgG in conjunction with TSA-Direct Green (NEN TM life science products).
Clonal analysis
Random lacZ expressing clones were induced at stage 9-10, essentially as described in Brewster and Bodmer (1995) . Briefly, lacZ-expressing clones were generated using the yeast flp/FRT site-specific recombination method according to Struhl and Basler (1993) . Homozygous hsp70-flp virgin females were crossed to Act-Draf-nuclacZ males. F1 embryos, hetero-or hemizygous for hsp70-flp and heterozygous for Act-Draf-nuclacZ, were collected and submitted to heatshock for 40 min at 37°C to induce the flp recombinase, which in turn causes the fusion of the actin promoter to the lacZ reporter gene. The embryos were aged at 25°C until they reached stage 13-15, then fixed and double labeled with mouse anti-J-galactosidase (Cappel, at 1:1000) and rabbit anti-Eve (1:10 000) antibodies.
Germline clones
To obtain embryos that were maternally as well as zygotically mutant for N (Chou and Perrimon, 1992) . The progeny females, which were heat-shocked at late larval stages to induce the flp recombinase, were then crossed to FM7 males. Of the eggs that these females laid, one half were maternally and zygotically mutant and the other half only maternally mutant N. Both types of progeny could easily be distinguished from one another because of the severe CNS hypertrophy of the maternally and zygotically N mutant embryos, which is much weaker in maternal-only N mutants.
numb and N intra overexpression
Homozygous lines of UAS-numb and UAS-N intra were crossed to homozygous Twi-Gal4;24B-Gal4 flies, which causes expression of the transgenes in the transheterozygous progeny embryos to be expressed in essentially all mesoderm shortly after gastrulation until late in embryogenesis (as determined by UAS-lacZ expression, data not shown). Conditional expression of N intra was achieved by elevating the incubation temperature of 6-7 h old hsN intra embryos (mid-to late stage 11), for 30 min to 37°C.
